Patent 7993644 was granted and assigned to Purdue Pharma on August, 2011 by the United States Patent and Trademark Office.
The present invention provides antibodies capable of binding to human tissue factor, which do not inhibit tissue factor mediated blood coagulation compared to a normal plasma control. Further described are methods of making and methods of using the antibodies of the invention.